Dr. Ronald Buckanovich, MD

Claim this profile

UPMC Hillman Cancer Center

Studies Thyroid Cancer
Studies Peritoneal Carcinoma
1 reported clinical trial
2 drugs studied

Affiliated Hospitals

Image of trial facility.
UPMC Hillman Cancer Center

Clinical Trials Ronald Buckanovich, MD is currently running

Image of trial facility.

Vismodegib + Atezolizumab

for Ovarian Cancer

This trial will treat patients with platinum resistant ovarian, fallopian tube or primary peritoneal cancer as defined by a progression free interval within six months of completion of most recent platinum-based treatment with a combination of vismodegib and atezolizumab. Despite recent improvements in treatment of ovarian cancer with the introduction of PARP inhibitors, response rates to therapy in the platinum resistant setting remain dismal with response rates of only 10-20% reported for single agent cytotoxic therapies. Given the poor prognosis and limited treatment options for these patients, this population is considered appropriate for trials of novel therapeutic candidates.
Recruiting1 award Phase 2

More about Ronald Buckanovich, MD

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Ronald Buckanovich, MD has experience with
  • Atezolizumab
  • Vismodegib
Breakdown of trials Ronald Buckanovich, MD has run
Thyroid Cancer
Peritoneal Carcinoma
PARP Inhibitors
Hedgehog Inhibitor
Ovarian Cancer

Other Doctors you might be interested in

Diwakar Davar, MDUPMC Cancer Center
Jason Luke, MDUPMC Hillman Cancer Center
Leonard J. ApplemanUniversity of Pittsburgh Medical Center

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ronald Buckanovich, MD specialize in?
Ronald Buckanovich, MD focuses on Thyroid Cancer and Peritoneal Carcinoma. In particular, much of their work with Thyroid Cancer has involved treating patients, or patients who are undergoing treatment.
Is Ronald Buckanovich, MD currently recruiting for clinical trials?
Yes, Ronald Buckanovich, MD is currently recruiting for 1 clinical trial in Pittsburgh Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Ronald Buckanovich, MD has studied deeply?
Yes, Ronald Buckanovich, MD has studied treatments such as Atezolizumab, Vismodegib.
What is the best way to schedule an appointment with Ronald Buckanovich, MD?
Apply for one of the trials that Ronald Buckanovich, MD is conducting.
What is the office address of Ronald Buckanovich, MD?
The office of Ronald Buckanovich, MD is located at: UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania 15232 United States. This is the address for their practice at the UPMC Hillman Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top